What are the recommended treatment options for bacterial vaginosis in women, including first‑line and alternative therapies?

Treatment for Bacterial Vaginosis in Women

For symptomatic bacterial vaginosis in non-pregnant women, treat with metronidazole 500 mg orally twice daily for 7 days as first-line therapy. 1

First-Line Treatment Options (Equally Recommended)

The CDC guidelines establish three equally efficacious first-line regimens 1:

• Metronidazole 500 mg orally twice daily for 7 days (preferred for systemic effect)
• Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days
• Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days

Important caveat: The vaginal clindamycin cream appears less efficacious than the metronidazole regimens 1. Therefore, oral or intravaginal metronidazole should be prioritized over clindamycin cream when choosing among first-line options.

Critical Patient Counseling Points

• Alcohol avoidance: Patients must avoid consuming alcohol during metronidazole treatment and for 24 hours after completion 1
• Barrier method warning: Clindamycin cream and ovules are oil-based and weaken latex condoms and diaphragms 1

Alternative Regimens (Lower Efficacy)

Use these only when first-line options fail or are contraindicated 1:

• Metronidazole 2g orally as single dose (lower efficacy, use only for adherence concerns)
• Clindamycin 300 mg orally twice daily for 7 days
• Clindamycin ovules 100g intravaginally once at bedtime for 3 days

The single-dose metronidazole regimen has documented lower efficacy and should be reserved for situations where adherence to multi-day therapy is unlikely 1.

Special Populations

Pregnant Women

All symptomatic pregnant women must be tested and treated due to associations with premature rupture of membranes, preterm labor, preterm birth, postpartum endometritis, and post-cesarean wound infection 1.

Recommended regimens for pregnancy:

• Metronidazole 250 mg orally three times daily for 7 days 1
• Clindamycin 300 mg orally twice daily for 7 days 1

Critical pregnancy-specific guidance:

• Use systemic therapy only (oral medications) 1
• Avoid topical agents during pregnancy 1
• Never use clindamycin cream in pregnancy - three trials demonstrated increased adverse events including prematurity and neonatal infections 1
• Multiple studies confirm metronidazole has no consistent association with teratogenic or mutagenic effects 1

High-risk pregnant women (prior preterm delivery): Consider screening and treating asymptomatic BV, as treatment reduced preterm delivery in 3 of 4 randomized trials 1. Screen and treat at the first prenatal visit 1.

Allergy or Intolerance

• If metronidazole allergy: Use clindamycin cream or oral clindamycin 1
• If metronidazole intolerance (not allergy): Consider metronidazole gel 1
• Never give metronidazole vaginally to patients with oral metronidazole allergy 1

HIV-Infected Women

Treat identically to HIV-negative women with the same regimens 2, 3

Recurrent BV Management

Recurrence occurs in 50-80% of women within one year 4, 5. For recurrent disease:

1. First recurrence: Use any of the recommended first-line regimens 1
2. Persistent recurrence: Extended metronidazole 500 mg twice daily for 10-14 days 5
3. If still ineffective: Metronidazole gel 0.75% for 10 days, then twice weekly for 3-6 months 5

No long-term maintenance regimen is currently recommended by guidelines 1, though extended suppressive therapy shows promise in research 5.

Partner Management

Do not treat sex partners routinely. Clinical trials demonstrate that partner treatment does not affect the woman's response to therapy or recurrence rates 1.

Follow-Up

• No follow-up needed if symptoms resolve 1
• Exception: Pregnant women should have follow-up evaluation at 1 month post-treatment to verify cure 2, 3
• Advise patients to return if symptoms recur 1

Pre-Procedural Considerations

Screen and treat BV before:

• Surgical abortion - reduces postabortion PID by substantial margins 1
• Hysterectomy - reduces post-operative infectious complications by 10-75% 1

More data needed before recommending routine screening before other invasive procedures 1.

Common Pitfalls to Avoid

1. Do not use probiotics or douching - no data support their use for BV treatment 1
2. Do not use clindamycin cream in pregnancy - associated with adverse neonatal outcomes 1
3. Do not treat partners - wastes resources without benefit 1
4. Do not use single-dose metronidazole as first-line - lower efficacy than 7-day regimen 1
5. Do not forget alcohol counseling with metronidazole - causes disulfiram-like reaction 1